THORACIC SURGERY

We specialize in advancing clinical research in thoracic surgery, focusing on diseases and disorders of the chest including the lungs, esophagus, mediastinum, and chest wall. Our research efforts support the development of innovative surgical techniques, minimally invasive procedures, and adjunct therapies aimed at improving patient outcomes, reducing complications, and enhancing recovery.

Our experienced team collaborates closely with leading thoracic surgeons and multidisciplinary specialists to conduct rigorous clinical trials across a range of thoracic conditions.

thoracic

Key Areas of Research:

  • Lung Cancer Surgery (including minimally invasive video-assisted thoracoscopic surgery - VATS)
  • Esophageal Surgery for cancers and motility disorders
  • Mediastinal Tumors and Masses
  • Chest Wall Reconstruction and trauma repair
  • Pleural Diseases including pneumothorax and pleural effusion management
  • Lung Transplantation and Pulmonary Endarterectomy
  • Tracheal and Bronchial Surgery
  • Enhanced Recovery After Surgery (ERAS) Protocols in thoracic surgery

Research Capabilities at Tupalin Research:

  • Access to specialized thoracic surgical centers with state-of-the-art operating theaters and imaging support
  • Expertise in trials involving minimally invasive techniques, robotic surgery, and novel surgical devices
  • Electronic Data Capture (EDC) for perioperative and postoperative outcome tracking
  • IVRS/IWRS Systems for efficient patient randomization and treatment management
  • Central Laboratory Services supporting biomarker and histopathological evaluations
  • CTMS for streamlined trial management and compliance with regulatory requirements
  • Collaboration in multidisciplinary protocols involving oncology, pulmonology, and anesthesiology

Our Commitment:

We are dedicated to driving innovation in thoracic surgery through clinical research that prioritizes patient safety, precision, and enhanced quality of life. By fostering collaboration between surgeons, researchers, and industry partners, we aim to accelerate the development of cutting-edge surgical solutions for thoracic diseases.

Together, we are shaping the future of thoracic care—improving survival and recovery, one clinical trial at a time.